Annovis Bio (ANVS)
(Delayed Data from NYSE)
$12.16 USD
-0.95 (-7.25%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $12.49 +0.33 (2.71%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/20/2024
Time: -- |
6/2024 | $-0.70 | 0.00% |
Earnings Summary
For their last quarter, Annovis Bio (ANVS) reported earnings of -$0.72 per share, beating the Zacks Consensus Estimate of $-0.87 per share. This reflects a positive earnings surprise of 17.24%. Look out for ANVS's next earnings release expected on August 20, 2024. For the next earning release, we expect the company to report earnings of -$0.70 per share, reflecting a year-over-year increase of 34.58%.
Earnings History
Price & Consensus
Zacks News for ANVS
Inovio (INO) Up as Lead Drug Gets Innovative Medicine Tag in UK
ANVS: What are Zacks experts saying now?
Zacks Private Portfolio Services